A conditional time for the cosmetologist for trading illegal fillers
In Russia, a signs of cosmetology for the market of cosmetology are issued: a large supplier of drugs not registered in the country used in injection cosmetology, even received a conditional, but not a fine, as it usually happens. Despite this precedent, the share of the gray market of fillers and botulinum toxins remains significant, more than half of the injections of beauty is made semi -legally.
As Kommersant discovered in the Mosgorsud Foard, the appellate instance in March 2025 softened the verdict of the Savelovsky District Court of Moscow, who has appointed Balata Beybulatov in the autumn of the Internet in the case of Internet trading in Russia (paragraph 2 of article 238.1 of the Criminal Code of the Russian Federation). The appeal reduced this period by three months and left a fine of 1.5 million rubles. Bulat Beybulatov was registered as an individual entrepreneur engaged in real estate management should be from the SPARK base.
Two other defendants in this case – Ramazan Magomedov and Ulmeskhan Abdulkhalikov did not achieve mitigation. Each of them has been appointed five -year conditional term and a fine of 1 million rubles. All three defendants pleaded guilty and refused to testify in court.
As follows from the case file, Bulat Beybulatov created several sites through which he sold fillers not registered in Russia.
Ramazan Magomedov received orders and agreed with buyers about the conditions of transactions, and Ulmeskhan Abdulkhalikov was looking for premises for storage of products. The investigation proved the fact of trade by illegal drugs by making a control purchase. At the same time, emphasizes the CEO of the Law Company « Miter » Yuri Mirzoev, sellers of illegal fillers were convicted without the presence of victims.
Bulat Beybulatov did not respond to the request “Kommersant”. Lawyer Omar Ibrahimov, who represented his interests when pronouncing the sentence, did not comment on the “Kommersant” process.
This verdict is really signful for the cosmetology market, says President of the Association of Enterprise and Beauty Professions Lyalya Sadykov. According to her, for the first time, a large supplier of gray drugs received a conditional, but a term, not a fine, as is usually the case. According to the Kommersant source in the market, the turnover of the business of Bulat Beibulatov was estimated at about 2 billion rubles. per year.
As stated in the case file, on the sites created by Baibulatov Balata, Dermalax Deep Plus fillers, Celosome Mid were sold to correct facial wrinkles, Celosome implant for correcting the cheekbones and chin, as well as Liporase used to remove excess hyaluronic acid, on average for the average for the average for 2–2.5 thousand rubles. For packaging. At the same time, in South Korea, where these funds are produced, their minimum price of $ 30, excluding delivery costs, found “Kommersant” on the sites of the clinics of the aesthetic medicine of this country.
Fillers and botulinum toxins, imported without registration, can cost three to four times cheaper than registered drugs, notes Lyalya Sadykova. “The consumer does not always understand what savings are achieved,” the expert adds.
According to the estimates of the consulting company “Right to Health”, the entire injection cosmetology market in Russia in 2024 was estimated at 44 billion rubles. (See “Kommersant” from March 14). According to analysts, about half of cosmetic procedures are carried out semi -legal in Russia. Mrs. Sadykova gives the same figure.
According to her, now the gray market is fed by a large number of pseudo -enhancing centers for cosmetologists. After such courses, cosmetologists begin to do without a medical education. Yuri Mirzoev also notes that until recently, control in this area was not strict enough, but now the opposite situation is observed. According to the lawyer, the case of Bulat Beibulatov can become a kind of precedent: Art. 238.1 of the Criminal Code is relatively new, and the practice of its application is only formed.